Loading…
4th European Clinical Quality Risk Management Forum has ended
Back To Schedule
Tuesday, February 25 • 1:30pm - 2:15pm
The Impact of ICH E6 and E8 Revisions

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Understand How and Why GCP is Being Modernized Through Revisions to ICH E6 and E8 and What This Means For Today’s Operations  
  • Evaluate the basis for the modernization and goals meant to be achieved
  • Understand the approach to the modernization from a tactical perspective
  • Introduce evolving quality concepts and critical to quality factors in clinical trial design and execution
  • Assess what these current and upcoming changes mean for your
Speakers
avatar for Kerstin Koenig

Kerstin Koenig

Vice President, Research and Development Quality, Bristol-Myers Squibb Company, United States
Kerstin Koenig, PhD is the Head of Research & Development Quality, Bristol Myers Squibb. In this role, she is responsible for the development and strategic oversight of the world-wide quality assurance and quality management activities in the area of Product Development Quality, GLP... Read More →

Tuesday February 25, 2020 1:30pm - 2:15pm PST
  General Session